Relation of airway responsiveness to salbutamol and to methacholine in smokers

Medical Science Monitor

Volumn 11, Issue 7, 2005, Pages

  Boskabady, Mohammad Hossein ^a   Farhadi, Named ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adrenoceptor; Airway responsiveness; Methacholine; Salbutamol; Smoking

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; METHACHOLINE; SALBUTAMOL;

ADULT; AIRWAY CONDUCTANCE; AIRWAY DYNAMICS; AIRWAY RESPONSIVENESS; ARTICLE; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DRUG EFFECT; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; MALE; NORMAL HUMAN; SMOKING; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; FORCED EXPIRATORY FLOW RATES; HUMANS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; RESPIRATORY SYSTEM; SMOKING;

EID: 22244435282     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Briton JR, Burney PG, Chinn S te al: The relationship between change in airway reactivity and change in respiratory symptoms and medication in a community study. Am Rev Respir Dis, 1988; 138: 530-34
2. Sparrow D, O'Conner G, Colton Th Barry ChL, Weiss ST: The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased level of pulmonary function. Am Rev Respir Dis, 1987; 135: 1255-26
3. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE: Methacholine bronchial responsiveness in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax, 1994; 39: 912-18
4. Auerbach O, Hammond EC, Garfinkel L, Benante C: Relation of smoking and age to emphysema. Whole-lung section study. N Engl J Med, 1972; 286: 853-57
5. Pride NB, Taylor RG, Lim TK te al: Bronchial hyperresponsiveness as a risk factor for progressive airflow obstruction in smokers. Bull Eur Physiopathol Respir, 1987; 23: 369-77
6. Creveri I, Bruschi C, Zoia M te al: Smoking habit and bronchial reactivity in normal subjects. Am Rev Respir Dis, 1989; 140: 191-96
7. Gerrard JW, Cockrot DW, Mink JT te al: Increased non-specific bronchial reactivity in cigarette smokers with normal lung function. AM Rev Respir Dis, 1980; 122: 577-81
8. Buczko GB, Day A, Vanderdoelen JL te al: Effect of cigarette and short-term smoking cessation on airway responsiveness to inhaled methacholine. Am Rev Respir Dis, 1984; 129: 12-14
9. Mullen JB, Wiggs BR, Wright JL te al: Nonspecific airway reactivity in cigarette smokers. Relationship to airway pathology and baseline lung function. Am Rev Respir Dis, 1986; 133: 120-25
10. Casale TB, Barry JR, Donnelly AL, Weiler J: Airway responses to methacholine in asymptomatic non-atopic cigarette smokers. J Appl Physiol, 1987; 62: 1888-92
11. 1 in male smokers and ex-smokers. Thorax, 1985; 40: 9-16
12. Martinez F, Antognoni G, Macri F te al: Parental smoking enhances bronchial responsiveness in nine-year-old children. Am Rev Respir Dis, 1988; 138: 518-23
13. Harvey JE, Tattersfield AE: Airway response to salbutamol: Effect of regular salbutamol inhalations in normal, atopic and asthmatic subjects. Thorax, 1982; 37: 280-87
14. Holgate ST, Stubbs WA, Wood PJ te al: Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci, 1980; 59: 155-61
15. Harvey JE, Baldwin CJ, Wood PJ te al: Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sc, 1981; 60: 579-85
16. Barnes PJ, Pride NB: Dose response curves to inhaled beta-adrenoceptor agonist in normal and asthmatic subjects. Br J Clin Pharmacol, 1983; 15: 677-82
17. Boskabady MH, Snashall PD: Bronchial responsiveness to beta-adrenergic stimulation and enhanced beta-blockade in asthma. Respirology, 2000; 5: 111-18
18. Boskabady MH, Saadatinejad M: Airway responsiveness to a beta-adrenergic agonist (salbutamol) in asthma. J Asthma, 2003; 40: 917-25
19. Heaton RW, Gillett MK, Snashall PD: Morning-evening changes in airway responsiveness to methacholine in normal and asthmatic subjects: analysis using partial flow volume curves. Thorax, 1988; 43: 727-28
20. Gillett MK, Snashall PD: Measurement of pharmacological antagonism produced by atropine in bronchi of normal and asthmatic subjects. Eur Respir J, 1988; 1: 27-33
21. American Thoracic Society: Standardization of spirometry: 1994 Update. Official Statement of American Thoracic Society. Am J Respir Crit Car Med, 1995; 152: 1107-36
22. Boskabady MH, Snashall PD: Enhanced muscarinic receptor blockade with atropine in the asthmatic tracheobronchial tree: Evidence for increased drug delivery in asthma. Am Rev Respir Dis, 1992; 145: 756-61
23. Sterk PG, Bel EH: Bronchial hyperresponsiveness. The need for a distinction between hypersensitivity and excessive airway narrowing. Eur Respir J, 1989; 2: 267-74
24. Lange P, Groth S, Nyboe J te al: Effects of smoking and changes in smoking habits on the decline of FEV1. Eur Respir J, 1989; 2: 811-16
25. Bosken CH, Wiggs BR, Pare PD, Hogg JC: Small airway dimensions in smokers with obstruction to airflow. Am Rev Respir Dis, 1990; 142: 563-70
26. Aparici M, Fernandez Gonzalez AL, Alegria E: Respiratory function tests, differences between smokers and nonsmokers: Effects of withdrawal. Rev Clin Esp, 1993; 192: 169-72
27. Lubinski W, Targowski T, Frank-Piskorska A: Evaluation of tobacco smoking on pulmonary function in young men. Pneumonol Alergol Pol, 2000; 68: 226-31
28. Hogg JC, Macklem PT, Thurlbeck MW: Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med, 1968; 278: 1355-60
29. Berend N, Wright JL, Thurlbeck MW te al: Small airways disease: reproducibility of measurements and correlation with lung function. Chest, 1981; 79: 263-68
30. Wright JL, Lawson LM, Pare PD te al: The detection of small airways disease. Am Rev Respir Dis, 1984; 129: 989-94
31. Trigg CJ, Bennett JB, Tooly M te al: A general practice based survey of bronchial hyperresponsiveness and its relations to symptoms, sex, age, atopy and smoking. Thorax, 1990; 45: 866-72
32. Chung KF, Jeyasingh K, Snashall PD: Influence of airway calibre on the intra-pulmonary dose and distribution of inhaled aerosol in normal and asthmatic subjects. Eur Respir J, 1988; 1: 890-95
33. Gillett MK, Briggs BA, Snashall PD: The influence of aerosol retention and pattern of deposition on bronchial responsiveness to atropine and methacholine. Am Rev Respir Dis, 1989; 140: 1727-33
34. Pendry YD: Neural control of airways smooth muscle. Pharmac Ther, 1993; 57: 171-202
35. Padrid P, Snook S, Finucane T te al: Persistent airway hyperresponsiveness and histologic alteration after chronic antigen challenge in cats. Am J Respir Crit Care, 1995; 151: 184-93
36. Booth H, Richmond I, Ward C te al: Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med, 1995; 152: 45-52
37. Nisikawa M, Kakemisu N, Ito T: Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor- B activation and IL-8 mRNA expression in guinea pigs in vivo. AMJ Respir Cell Mol Biol, 1999; 20: 189-98
38. Finkelsteine R, Fraser RS, Ghezzo H: Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med, 1995; 152: 1666-72
39. Cosio MG, Majo J, Cosio MG: Inflammation of the airways and lung parenchyma in COPD: Role of T cells. Chest, 2002; 121: 160s-165s
40. Barns AR, Hosford SP, Dunn LA: Respiratory epithelial permeability after cigarette smoke exposure in guinea pigs. J Appl Physiol, 1989; 66: 2109-16
41. Taylor RG, Agnew JE, Francis RA te al: Respiratory epithelial permeability is unrelated to bronchial reactivity and small airway function in young smokers and nonsmokers. Eur Respir J, 1988; 1: 319-23
42. Schwartz J, Schindler C, Zemp E te al: Predictors of methacholine responsiveness in a general population. Chest, 2002; 122: 812-20
43. Boskabady MH, Dehghani H, Esmailzadeh M: Lung function tests (LFTs) and their reversibility in smokers compared to nonsmokers. Turkish Respir J, 2002; 3(Suppl. 1): 44
44. Mosiewicz J, Myśliński W, Jaszyna M, Hanzlik J: Application of nonspecific bronchial challenge tests - when, how and why? Med Sci Monit, 1999; 5(3): 591-95